Drug Discovery Biology
Other research themes
See the latest news
A new Australian population-based cohort study by Monash University has directly compared two classes of drugs used to treat type 2 diabetes (T2D) and found that one of the two classes is associated with a greater reduction of major adverse
The Monash Institute of Pharmaceutical Sciences has been awarded $5.5 million in NHMRC grants to push forward four new exciting research projects.
Researchers from the Monash Institute of Pharmaceutical Sciences will lead three projects that will receive a total of $1.84 million through the Australian Research Council’s Discovery Program.
Dr Sarah Turpin-Nolan is among 16 highly skilled researchers, clinicians and professionals to secure an industry placement under a coveted national fellowship program.
Professor Arthur Christopoulos spoke at a symposium hosted by the Australian Academy of Science and the Australian Academy of Law on October 18.
A Monash-led team of researchers has been funded $3.8 million in the current round of Medical Research Future Fund to develop a new class of drug compounds to counter drug-resistant epilepsy.
MIPS will be home to two researchers awarded close to $1M in funding through the ARC Discovery Early Career Researcher Award scheme.
Three outstanding mid-career researchers and new ARC Future Fellows, Associate Professor Darren Creek, Dr Nicholas Veldhuis and Dr Roey Elnathan have received close to $3M in funding to advance research projects addressing a range of medical needs.